S. 3081In Committee
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025
Establishes a reciprocal approval pathway for certain drugs biologics and medical devices with unmet medical need when approved in specified other countries
Plain-English overview
What this bill does
Establishes a reciprocal approval pathway for certain drugs biologics and medical devices with unmet medical need when approved in specified other countries
Key points
- Establish reciprocal approval pathway
- Require sponsor eligibility showing
- Allow FDA postmarket studies
- Allow congressional approval resolution
Current status
Where it stands
Status
In Committee
Latest action
2025-10-30 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
undefinedHealth